Opportunity ID: 215813

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-AI-12-059
Funding Opportunity Title:: Autoimmunity Centers of Excellence, Clinical Research Program (UM1)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Jan 15, 2013
Last Updated Date::
Original Closing Date for Applications:: Jun 13, 2013
Current Closing Date for Applications:: Jun 13, 2013
Archive Date:: Jul 14, 2013
Estimated Total Program Funding:: $ 1,200,000
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: Special district governments
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: This FOA solicits applications to participate in the Autoimmunity Centers of Excellence (ACE) program, a cooperative network intended to improve the understanding and treatment of autoimmune diseases (www.autoimmunitycenters.org). The ACE program was founded on the premise that collaboration among basic and clinical scientists can accelerate both fundamental and applied research. For this reissuanc, the formerly integrated Centers are divided into Basic and Clinical research programs. This FOA solicits applications for the Clinical research program; a companion FOA solicits applications for the Basic research program. The members of the Basic and Clinical ACE will work together to design and conduct studies of mechanisms of action of immune-modulating agents tested in clinical trials.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Package No: 1

Related Documents